Mayo Clinic unravels a mystery disease for Minnesota lawyer

March 31, 2015 by Dan Browning, Star Tribune (Minneapolis)

Greg Widseth didn't know what hit him. The lawyer felt fine as he coached his son's ninth-grade basketball workout last March. He remembers smiling at a young woman as he left the building.

Now Widseth, who once had a photographic memory, is struggling to reconstruct the events that put him in the hospital and led his wife, a former emergency room nurse, to seek help from the Mayo Clinic.

Specialists at Mayo determined that Widseth, 47, was hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day.

Mayo is one the world's leaders in the diagnosis and treatment of autoimmune neurological diseases, an emerging specialty that drives about 2,500 patients a year to seek help at its Rochester campus. Widseth said neurologists near his home had no idea what to do for him after standard anti-seizure drugs failed to stop the lightning jolting his brain.

"They were like, 'Well, it just happens,'" said Widseth's wife, Nan. "No, it doesn't just happen," she said, recalling that her husband didn't even recognize her after the first seizures struck.

When it became clear that her husband wasn't getting better, she called her sister in Rochester, whose neighbor happened to be Dr. Jeffrey Britton, a Mayo neurologist specializing in autoimmune encephalitis. Britton and his colleague, Dr. Andrew McKeon, a neuroimmunologist, agreed to see Widseth within a few days.

Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that Widseth had antibodies known to target certain brain cells. That prompted a round of immunosuppressant drugs that had him feeling nearly normal in just four days.

"It was like a light switch was turned off," Widseth said.

Patients who don't get prompt immunosuppressant therapy can suffer serious memory problems or permanent seizures, Britton said. "Getting here quickly made a huge difference."

In the 1960s, scientists discovered that patients with some types of cancer can develop that attack the central nervous system. The immune system sends antibodies to attack the cancer, but sometimes they "cross-react" with normal , leading to neurological diseases, Britton said.

"It's kind of an innocent-bystander effect," he said.

Then Mayo researchers started seeing patients who had nerve diseases without the underlying cancers, and it occurred to them that the patient's antibodies might be to blame.

Widseth had one of the more common ones, known to attack the brain's limbic system, which is involved in the emotions, memory and learning. But he had no cancer.

Some patients have a fever shortly before the onset of their illness, so it's thought that perhaps they had an infection that set off the , Britton said.

Not Widseth. The mystery deepened.

"I would say at least half the people I've seen don't have an obvious trigger that we can pinpoint," Britton said. "So we don't know right now what sets it off."

Dr. Sean Pittock set up the nation's first autoimmune neurology clinic at Mayo in 2006, and he now directs the Neuroimmunology Laboratory and the Center for MS and Autoimmune Neurology. He said technological advances in the past decade have led to "an explosion" in the identification of antibodies that trigger neurological disorders.

Autoimmune responses have been identified as the cause behind a variety of diseases, including dementia, epilepsy, encephalopathy and some eye diseases and movement disorders, Pittock said.

Some forms can even mimic psychiatric disorders, such as a potentially lethal one with the unwieldy name anti-NMDA receptor encephalitis. Susannah Cahalan, a reporter with the New York Post, brought attention to the disease in her bestselling memoir, "Brain on Fire: My Month of Madness," which is being made into a movie.

More recently, Dallas Cowboys tackle Amobi Okoye spent three months in a medically induced coma as he fought the disease.

Recent research suggests the disease may be triggered in encephalitis patients by the same herpes simplex virus responsible for cold sores.

Last April, Mayo published the results of a trial evaluating patients with presumed autoimmune epilepsy in the journal Neurology. Now the idea is spreading to other .

Autoimmune spinal cord disease and autoimmune vision problems "have also been revolutionized by Mayo labs," Pittock said.

Now, Pittock said, researchers are exploring autoimmune disorders that cause serious, painful gastrointestinal disease. "Remember, the gut has 100 million neurons," he said.

Since getting the right diagnosis, Widseth has been able to stay on the job and said he's grateful he got treatment before much damage was done.

"I've tried eight felony cases to verdicts," he said.

Widseth admits to struggling with some memory lapses, some of which may be permanent. But he's found techniques to keep him on task, such as keeping good lists and asking people to put important things in writing. Only time will tell if he's out of danger.

"Relapse happens in about 25 percent of the cases - but that's usually in the first year," Widseth said. "I'm almost beyond that."

Explore further: Antibodies to brain proteins may trigger psychosis

Related Stories

Antibodies to brain proteins may trigger psychosis

March 5, 2015
Antibodies defend the body against bacterial, viral, and other invaders. But sometimes the body makes antibodies that attack healthy cells. In these cases, autoimmune disorders develop.

Immune response may cause harm in brain injuries, disorders

July 24, 2014
Could the body's own immune system play a role in memory impairment and cognitive dysfunction associated with conditions like chronic epilepsy, Alzheimer's dementia and concussions? Cleveland Clinic researchers believe so, ...

Immunotherapy associated with improved seizure outcomes among patients with autoimmune epilepsy

March 26, 2012
Early-initiated immunotherapy appears to be associated with improved seizure outcomes among patients with autoimmune epilepsy, according to a report published Online First by Archives of Neurology.

World Trade Center workers at increased risk of developing autoimmune diseases

March 16, 2015
A new study has found a strong link between prolonged work at the World Trade Center (WTC) site following the terrorist attacks of September 11, 2001 and the development of various autoimmune diseases including arthritis ...

Newly enlisted T-cell 'policemen' can slow down run-away immune system, scientist says

March 30, 2015
In research published in the March issue of Immunity, Saint Louis University scientists led by Daniel Hawiger, M.D., Ph.D., assistant professor of molecular microbiology and immunology, have discovered that potentially aggressive ...

Researchers stop neuromyelitis optica attacks with new therapy

October 9, 2012
Mayo Clinic researchers have identified a new therapy for patients with neuromyelitis optica that appears to stop inflammation of the eye nerves and spinal cord. NMO is a debilitating central nervous system disorder that ...

Recommended for you

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.